The primary outcome measures are the Assessment of DSM-IV Personality Disorders and the Clinician-Administered PTSD Scale for DSM-5. All participants are subject to single-blinded baseline, post-intervention and 3-, 6- and 12-month follow-up assessments. Three months after potential treatment with EMDR therapy, patients can receive treatment as usual for their PD. ![]() Participants will be allocated to either a treatment condition with EMDR therapy (ten biweekly 90-min sessions) or a waiting list. The Structured Clinical Interview for DSM-5 Personality Disorders will be used to determine the presence of a PD. In total, 159 patients with a PD will be included in a large multicentre single-blind randomized controlled trial. Lastly, experiences with EMDR therapy will be explored. Moreover, predictors of treatment success, symptom deterioration and treatment discontinuation will be assessed. ![]() In addition, the cost-effectiveness of EMDR therapy in the treatment of PDs is investigated. Furthermore, the effects of EMDR therapy on trauma symptom severity, loss of diagnosis, personal functioning, quality of life, and mental health outcomes will be determined. The primary purpose of the present study is to determine the effectiveness of EMDR therapy versus waiting list in reducing PD symptom severity. There is emerging evidence indicating that trauma-focused treatment using eye movement desensitization and reprocessing (EMDR) therapy aimed at resolving memories of individuals’ adverse events can be beneficial for this target group within a relatively short time frame. Existing recommended treatment options for personality disorders (PDs) are extensive and costly.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |